Fact CheckerSign in

NCT07622251Not yet recruiting

The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus

Sistemik Lupus Eritematozus Tanılı Bireylere Uygulanan Aerobik Egzersizlerin Kognitif Fonksiyonlar ve Hastalık Aktivitesi Üzerine Etkisi

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

Study Objective: To examine the effect of aerobic exercise on disease activity and cognitive functions in patients diagnosed with SLE. Study Goals: 1. To conduct comprehensive pre- and post-treatment (after 12 weeks) evaluations of SLE patients included in the study, and to determine their disease activity and cognitive levels. 2. To apply aerobic exercise to SLE patients for three months. 3. To analyze the effects of the aerobic exercise program on disease activity and cognitive functions.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
38 (estimated)
First submitted
10 May 2026
Start date
5 Jun 2026
Primary completion date
4 Jun 2027
Lead sponsor
Istanbul Galata University
Diseases
Lupus (SLE)
NCT number
NCT07622251

What you commit to

  • Study type: Interventional
  • Planned participants: 38
  • From 5 Jun 2026 to the primary completion date, 4 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of secondary rheumatic disease
  • Presence of active acute or chronic infection,
  • Acute renal failure,
  • Cardiac and pulmonary involvement,
  • Presence of musculoskeletal and joint disorders that prevent exercise testing,

Other

  • Body mass index (BMI) ≥ 30 kg/m2,
  • Pregnancy

Who the study is looking for

  • Having been diagnosed with SLE at least one year prior according to the American Rheumatology Association (ACR) diagnostic criteria
  • Being between 25-65 years of age
  • Not having received a neuropsychiatric diagnosis
  • Having medication adjusted and being on stable medication for 3 months
  • Not being involved in a regular exercise program
  • Having a Mini Mental Test score lower than 26.

Age in the registry: 25 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Galata University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.